Maxine Gowen - 31 May 2022 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Director
Signature
/s/ Edgar Cale, Attorney-in-Fact
Issuer symbol
PASG
Transactions as of
31 May 2022
Net transactions value
$0
Form type
4
Filing time
01 Jun 2022, 16:27:52 UTC
Previous filing
31 May 2022
Next filing
06 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 31 May 2022 Common Stock 40,000 $1.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in ratable increments of 1/12 of the total award on each monthly anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on each vesting date.